Quadrivalent Influenza Virus Split Vaccine (Anhui Zhifei Longcom Biopharma)
四价流感病毒裂解疫苗（安徽智飞龙科马生物）
Report date: 2026/01/27 16:58:50
Base Information
Drug NameQuadrivalent Influenza Virus Split Vaccine (Anhui Zhifei Longcom Biopharma)
Drug Alias NameN/A
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaDiscontinued
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A